Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 6Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2CNS 1

Conditions

Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 95Fluorouracil 84Capecitabine 75Gemcitabine 72Leucovorin 68Nivolumab 67Bevacizumab 63pembrolizumab 61Magnetic Resonance Spectroscopy 52Specimen Handling 50Irinotecan 50durvalumab 46Radiotherapy 42atezolizumab 40Cisplatin 39Paclitaxel 37Biopsy 37130-nm albumin-bound paclitaxel 34Cetuximab 30Carboplatin 27Albumin-Bound Paclitaxel 26Taxes 24Drug Therapy 20dehydroftorafur 19Radiation 19Ipilimumab 19tislelizumab 18Standard of Care 17Docetaxel 17trifluridine tipiracil drug combination 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Referral and Consultation × Gastrointestinal × Clear all
NCT05675059 2026-02-09

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
80 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06090643 2025-11-14

Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
9,745 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡